EC chi hơn 70 triệu USD mua thuốc remdesivir điều trị COVID-19

Nhằm đáp ứng nhu cầu cấp bách hiện nay cho các bệnh nhân mắc dịch viêm đường hô hấp cấp COVID-19 ở châu Âu, ngày 29/7, Ủy ban châu Âu (EC) thông báo đã đồng ý mua thuốc kháng virus remdesivir vốn khan hiếm của công ty dược phẩm Mỹ Gilead Sciences.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Thượng viện Mỹ phản đối siết quyền của tổng thống Trump trong cuộc chiến với Iran

Thượng viện Mỹ phản đối siết quyền của tổng thống Trump trong cuộc chiến với Iran

Thế giới
(Baothanhhoa.vn) - Thượng viện Mỹ đã bỏ phiếu bác Nghị quyết Quyền hạn Chiến tranh với tỷ lệ 47 phiếu thuận và 53 phiếu chống, qua đó không thông qua đề xuất yêu cầu Tổng thống Mỹ phải có sự chấp thuận của Quốc hội trước khi tiến hành các đợt tấn công tiếp theo nhằm vào Iran.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh